BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 32176799)

  • 1. A Retrospective Analysis of Risk Factors and Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Bacteremia in Nontransplant Patients.
    Xiao T; Zhu Y; Zhang S; Wang Y; Shen P; Zhou Y; Yu X; Xiao Y
    J Infect Dis; 2020 Mar; 221(Suppl 2):S174-S183. PubMed ID: 32176799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for carbapenem-resistant K. pneumoniae bloodstream infection and predictors of mortality in Chinese paediatric patients.
    Zhang Y; Guo LY; Song WQ; Wang Y; Dong F; Liu G
    BMC Infect Dis; 2018 May; 18(1):248. PubMed ID: 29855274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae.
    Hussein K; Raz-Pasteur A; Finkelstein R; Neuberger A; Shachor-Meyouhas Y; Oren I; Kassis I
    J Hosp Infect; 2013 Apr; 83(4):307-13. PubMed ID: 23313086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections in a Chinese Children's Hospital: Predominance of New Delhi Metallo-β-Lactamase-1.
    Dong F; Zhang Y; Yao K; Lu J; Guo L; Lyu S; Yang Y; Wang Y; Zheng H; Song W; Liu G
    Microb Drug Resist; 2018 Mar; 24(2):154-160. PubMed ID: 28594635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias.
    Micozzi A; Gentile G; Minotti C; Cartoni C; Capria S; Ballarò D; Santilli S; Pacetti E; Grammatico S; Bucaneve G; Foà R
    BMC Infect Dis; 2017 Mar; 17(1):203. PubMed ID: 28283020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology, management, and outcome of carbapenem-resistant Klebsiella pneumoniae bloodstream infections in hospitals within the same endemic metropolitan area.
    Cristina ML; Alicino C; Sartini M; Faccio V; Spagnolo AM; Bono VD; Cassola G; De Mite AM; Crisalli MP; Ottria G; Schinca E; Pinto GL; Bottaro LC; Viscoli C; Orsi A; Giacobbe DR; Icardi G;
    J Infect Public Health; 2018; 11(2):171-177. PubMed ID: 28668656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination Regimens for Treatment of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections.
    Gomez-Simmonds A; Nelson B; Eiras DP; Loo A; Jenkins SG; Whittier S; Calfee DP; Satlin MJ; Kubin CJ; Furuya EY
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3601-7. PubMed ID: 27044555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey.
    Trecarichi EM; Pagano L; Martino B; Candoni A; Di Blasi R; Nadali G; Fianchi L; Delia M; Sica S; Perriello V; Busca A; Aversa F; Fanci R; Melillo L; Lessi F; Del Principe MI; Cattaneo C; Tumbarello M;
    Am J Hematol; 2016 Nov; 91(11):1076-1081. PubMed ID: 27428072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthcare-associated carbapenem-resistant Klebsiella pneumoniae infections are associated with higher mortality compared to carbapenem-susceptible K. pneumoniae infections in the intensive care unit: a retrospective cohort study.
    Yao Y; Zha Z; Li L; Tan H; Pi J; You C; Liu B
    J Hosp Infect; 2024 Jun; 148():30-38. PubMed ID: 38513959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors, outcomes and genotypes of carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream infection: a three-year retrospective study in a large tertiary hospital in Northern China.
    Zheng SH; Cao SJ; Xu H; Feng D; Wan LP; Wang GJ; Xiao XG
    Infect Dis (Lond); 2018 Jun; 50(6):443-451. PubMed ID: 29303020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment outcome of non-carbapenemase-producing carbapenem-resistant Klebsiella pneumoniae infections: a multicenter study in Taiwan.
    Su CF; Chuang C; Lin YT; Chan YJ; Lin JC; Lu PL; Huang CT; Wang JT; Chuang YC; Siu LK; Fung CP
    Eur J Clin Microbiol Infect Dis; 2018 Apr; 37(4):651-659. PubMed ID: 29238934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Previous bloodstream infections due to other pathogens as predictors of carbapenem-resistant Klebsiella pneumoniae bacteraemia in colonized patients: results from a retrospective multicentre study.
    Giacobbe DR; Del Bono V; Bruzzi P; Corcione S; Giannella M; Marchese A; Magnasco L; Maraolo AE; Pagani N; Saffioti C; Ambretti S; Cardellino CS; Coppo E; De Rosa FG; Viale P; Viscoli C;
    Eur J Clin Microbiol Infect Dis; 2017 Apr; 36(4):663-669. PubMed ID: 27909821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections.
    Neuner EA; Yeh JY; Hall GS; Sekeres J; Endimiani A; Bonomo RA; Shrestha NK; Fraser TG; van Duin D
    Diagn Microbiol Infect Dis; 2011 Apr; 69(4):357-62. PubMed ID: 21396529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High mortality associated with inappropriate initial antibiotic therapy in hematological malignancies with Klebsiella pneumoniae bloodstream infections.
    Ma Z; Lai C; Zhang J; Han Y; Xin M; Wang J; Wu Z; Luo Y
    Sci Rep; 2024 Jun; 14(1):13041. PubMed ID: 38844581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors for Carbapenem-resistant
    Wang Z; Qin RR; Huang L; Sun LY
    Chin Med J (Engl); 2018 Jan; 131(1):56-62. PubMed ID: 29271381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of carbapenem resistance on epidemiology and outcomes of nonbacteremic Klebsiella pneumoniae infections.
    Ny P; Nieberg P; Wong-Beringer A
    Am J Infect Control; 2015 Oct; 43(10):1076-80. PubMed ID: 26190386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose tigecycline for the treatment of nosocomial carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A retrospective cohort study.
    Geng TT; Xu X; Huang M
    Medicine (Baltimore); 2018 Feb; 97(8):e9961. PubMed ID: 29465589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.
    Mouloudi E; Protonotariou E; Zagorianou A; Iosifidis E; Karapanagiotou A; Giasnetsova T; Tsioka A; Roilides E; Sofianou D; Gritsi-Gerogianni N
    Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1250-6. PubMed ID: 20973725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of mortality in multidrug-resistant Klebsiella pneumoniae bloodstream infections.
    Viale P; Giannella M; Lewis R; Trecarichi EM; Petrosillo N; Tumbarello M
    Expert Rev Anti Infect Ther; 2013 Oct; 11(10):1053-63. PubMed ID: 24073806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae.
    Wu D; Cai J; Liu J
    South Med J; 2011 Feb; 104(2):106-10. PubMed ID: 21258230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.